| PID_in_paper | age(yr) | gender | race/ethnicity | infection_duration | pre_ART_duration | ART | ART_duration | pre_suppression_duration | suppression_duration | proviral_DNA_copies_at_sampling | viral_RNA_copies_at_sampling | suppression_status | CD4_at_sampling | sample_comment |
|---|
| P3 | 58(yr) | F | African American | 15(yr) | namonths | TAF, FTC, BIC | 14.5(month) | na | | | 167(copies/mL) | not supressed | 803(cells/ul) | non suppressible viremia caused by 5prime-Leader defective proviral clone |
| P2 | 60(yr) | M | Caucasian/White | 31(yr) | namonths | TAF, FTC, BIC, FTR | 26.4(month) | na | | | 20(copies/mL) | not supressed | 793(cells/ul) | non suppressible viremia caused by 5prime-Leader defective proviral clone |
| P1 | 63(yr) | M | African American | 30(yr) | namonths | TAF, FTC, BIC | 7.8(month) | na | | | 58(copies/mL) | not supressed | 828(cells/ul) | non suppressible viremia caused by 5prime-Leader defective proviral clone |
| P4 | 60(yr) | M | Caucasian/White | 32(yr) | namonths | TAF, FTC, BIC, DOR, MVC | 27(month) | na | | | 3400(copies/mL) | not supressed | 610(cells/ul) | non suppressible viremia caused by 5prime-Leader defective proviral clone |
